Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 374.2 INR 0.53% Market Closed
Market Cap: 187B INR
Have any thoughts about
Eris Lifesciences Ltd?
Write Note

Eris Lifesciences Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eris Lifesciences Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Eris Lifesciences Ltd
NSE:ERIS
PP&E Net
â‚ą5.2B
CAGR 3-Years
89%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
PP&E Net
â‚ą76B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
PP&E Net
â‚ą62.2B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
4%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
PP&E Net
â‚ą112.5B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
PP&E Net
â‚ą36.3B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
0%
M
Mankind Pharma Ltd
NSE:MANKIND
PP&E Net
â‚ą31.4B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Eris Lifesciences Ltd
Glance View

Market Cap
186.9B INR
Industry
Pharmaceuticals

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-06-29. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals and nutrients (VMN). The firm's brands include Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited and Eris Healthcare Private Limited.

ERIS Intrinsic Value
1 082.77 INR
Overvaluation 21%
Intrinsic Value
Price

See Also

What is Eris Lifesciences Ltd's PP&E Net?
PP&E Net
5.2B INR

Based on the financial report for Jun 30, 2024, Eris Lifesciences Ltd's PP&E Net amounts to 5.2B INR.

What is Eris Lifesciences Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
56%

Over the last year, the PP&E Net growth was 39%. The average annual PP&E Net growth rates for Eris Lifesciences Ltd have been 89% over the past three years , 56% over the past five years .

Back to Top